U.S., May 5 -- ClinicalTrials.gov registry received information related to the study (NCT07563491) titled 'Comparison of Esomeprazole Versus Vonoprazan in Gastroesophageal Reflux Disease' on April 25.
Brief Summary: Local literature is deprived of data comparing the effectiveness of esomeprazole and vonoprazan in patients with gastroesophageal reflux disease (GERD). This study was planned with the objective of comparing the effectiveness of esomeprazole versus vonoprazan in patients diagnosed with GERD.
Study Start Date: Jan. 01, 2025
Study Type: INTERVENTIONAL
Condition:
Gastro Esophageal Reflux
Intervention:
DRUG: Esomeprazole
Patients received a once-daily dose of 20 mg of esomeprazole after the evening meal for 4 weeks.
DRUG: V...